140 related articles for article (PubMed ID: 21495174)
21. RASopathies: The musculoskeletal consequences and their etiology and pathogenesis.
Fowlkes JL; Thrailkill KM; Bunn RC
Bone; 2021 Nov; 152():116060. PubMed ID: 34144233
[TBL] [Abstract][Full Text] [Related]
22. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
[TBL] [Abstract][Full Text] [Related]
23. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
Ørstavik KH; Tangeraas T; Molven A; Prescott TE
Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
[TBL] [Abstract][Full Text] [Related]
24. Cell type-specific roles of RAS-MAPK signaling in learning and memory: Implications in neurodevelopmental disorders.
Ryu HH; Lee YS
Neurobiol Learn Mem; 2016 Nov; 135():13-21. PubMed ID: 27296701
[TBL] [Abstract][Full Text] [Related]
25. [Update on the treatment of RASopathies].
Duat-Rodriguez A; Hernandez-Martin A
Rev Neurol; 2017 May; 64(s03):S13-S17. PubMed ID: 28524213
[TBL] [Abstract][Full Text] [Related]
26. Modeling RASopathies with Genetically Modified Mouse Models.
Hernández-Porras I; Guerra C
Methods Mol Biol; 2017; 1487():379-408. PubMed ID: 27924582
[TBL] [Abstract][Full Text] [Related]
27. Excess of neuromuscular spindles in a fetus with Costello syndrome: a clinicopathological report.
Sinico M; Bassez G; Touboul C; Cavé H; Vergnaud A; Zirah C; Fleury-Feith J; Gettler S; Vojtek AM; Chevalier N; Amram D; Alsamad IA; Haddad B; Encha-Razavi F
Pediatr Dev Pathol; 2011; 14(3):218-23. PubMed ID: 20658932
[TBL] [Abstract][Full Text] [Related]
28. Clinical Manifestations of Noonan Syndrome and Related Disorders.
Breilyn MS; Mehta L
Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):428-434. PubMed ID: 31115194
[TBL] [Abstract][Full Text] [Related]
29. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
31. Disorders of the ras pathway: an introduction.
Viskochil DH
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):79-82. PubMed ID: 21495180
[No Abstract] [Full Text] [Related]
32. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
Schubbert S; Bollag G; Shannon K
Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
[TBL] [Abstract][Full Text] [Related]
33. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
Weiss B; Bollag G; Shannon K
Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
[TBL] [Abstract][Full Text] [Related]
34. Molecular Genetics of Noonan Syndrome and RASopathies.
Liao J; Mehta L
Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
[TBL] [Abstract][Full Text] [Related]
35. [Neonatal atrial tachycardia: suggestive clinical sign of Costello syndrome].
Laux D; Bajolle F; Maltret A; Bonnet D
Arch Pediatr; 2011 Oct; 18(10):1087-9. PubMed ID: 21885263
[TBL] [Abstract][Full Text] [Related]
36. Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes.
Papadopoulou A; Bountouvi E
Front Endocrinol (Lausanne); 2023; 14():1231828. PubMed ID: 37964950
[TBL] [Abstract][Full Text] [Related]
37. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
38. Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation.
van der Burgt I; Kupsky W; Stassou S; Nadroo A; Barroso C; Diem A; Kratz CP; Dvorsky R; Ahmadian MR; Zenker M
J Med Genet; 2007 Jul; 44(7):459-62. PubMed ID: 17412879
[TBL] [Abstract][Full Text] [Related]
39. Cardio-facio-cutaneous syndrome: phenotypic variability and differential diagnosis in 3 cases with de novo BRAF mutations.
Demir E; Mancano G; Pomponi MG; Ozcelik A; Gucuyener K; Neri G
Neuropediatrics; 2010 Jun; 41(3):127-31. PubMed ID: 20859831
[TBL] [Abstract][Full Text] [Related]
40. Autism Spectrum Disorder Symptom Profile Across the RASopathies.
Geoffray MM; Falissard B; Green J; Kerr B; Evans DG; Huson S; Burkitt-Wright E; Garg S
Front Psychiatry; 2020; 11():585700. PubMed ID: 33519543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
